Interface Biologics, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Interface Biologics, Inc. (IBI) is a medical device company that develops transformative biomedical polymer technology. The company offers products such as anti-thrombogenic devices and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBIs technologies include endexo, kinesyx, and epidel. The company provides combination drug delivery devices including Epidel, an anti-infective polymer; and Kinesyx, bioactive oligomers among others. Its products improve the safety and effectiveness of implantable medical devices. The company also offers products compatible with biologics, pharmaceuticals, and medical materials. IBI is headquartered in Toronto, Ontario, Canada.

Interface Biologics, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Interface Biologics, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interface Biologics, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
Interface Biologics, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interface Biologics, Inc., Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Interface Biologics, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Interface Biologics, Inc., Medical Equipment, Deal Details 10
Venture Financing 10
Interface Biologics Raises Funds Through Extended Series B Venture Financing 10
Interface Biologics Secures US$1 Million In Venture Financing 10
Interface Biologics Secures US$7 Million In Series B Financing Round 11
Partnerships 12
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 12
Interface Biologics Enters Into Licensing Agreement With Navilyst Medical 13
Fresenius Medical Care Extends Licensing Agreement with Interface Biologics 14
Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 15
Interface Biologics Enters Into Co-Development Agreement With BASF Future 16
Interface Biologics, Inc. - Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List Of Tables


Interface Biologics, Inc., Medical Equipment, Key Facts 1
Interface Biologics, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Interface Biologics, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interface Biologics, Inc., Medical Equipment Deals By Type, 2011 to YTD 2017 6
Interface Biologics, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interface Biologics, Inc., Deals By Market, 2011 to YTD 2017 8
Interface Biologics, Inc., Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Interface Biologics Raises Funds Through Extended Series B Venture Financing 10
Interface Biologics Secures US$1 Million In Venture Financing 10
Interface Biologics Secures US$7 Million In Series B Financing Round 11
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 12
Interface Biologics Enters Into Licensing Agreement With Navilyst Medical 13
Fresenius Medical Care Extends Licensing Agreement with Interface Biologics 14
Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 15
Interface Biologics Enters Into Co-Development Agreement With BASF Future 16
Interface Biologics, Inc., Key Competitors 17
Interface Biologics, Inc., Key Employees 18

List Of Figures


Interface Biologics, Inc., Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Interface Biologics, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Interface Biologics, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Interface Biologics, Inc., Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Interface Biologics, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Interface Biologics, Inc., Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Interface Biologics, Inc., Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Interface Biologics, Inc., Medical Equipment, Deals by Market, 2011 to YTD 2017 8

Global Neural Control Interface Market Research Report 

In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Neural Control Interface Report by Material, Application, and Geography Global

USD View Report

Global Implantable Brain-computer Interface Market Research Report 2021-2025

Implantable brain-computer interface (BCI) technology is an expanding area of engineering research now moving into clinical application. In the context of China-US trade war and COVID-19 epidemic, it will have

USD 2850 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available